Literature DB >> 8380846

Functional integrity of benzodiazepine receptors of the geniculo-striate visual pathways in Creutzfeldt-Jakob disease. A pharmacological evoked potential study.

U Aguglia1, R L Oliveri, A Gambardella, A Quattrone.   

Abstract

We evaluated the effects of flumazenil (FMZ), a high-affinity benzodiazepine receptor antagonist, on flash-evoked visual potentials (FEPs) in a patient with Creutzfeldt-Jacob disease (CJD). FEPs were recorded in three different consecutive sessions: (1) basal condition, without any pharmacological treatment; (2) 3.5 min after i.v. administration of 5 mg FMZ; (3) 1 min after i.v. administration of 10 mg diazepam (DZP). FMZ provoked a marked increase in the amplitude as well as evident shortening of the latency of early FEP components. DZP reversed these effects. These results are in agreement with our previous findings of anatomical and functional integrity of the geniculo-striate pathways in human CJD and demonstrate functional integrity of benzodiazepine receptors in this visual system in CJD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380846     DOI: 10.1007/bf00838442

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Sensory evoked potentials in Creutzfeldt-Jakob disease.

Authors:  U Aguglia; G Farnarier; H Regis; R L Oliveri; A Quattrone
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

2.  Evolution of EEG and visual evoked response changes in Jakob-Creutzfeldt disease.

Authors:  R G Lee; R D Blair
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1973-08

3.  Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials.

Authors:  D A Burke; K W Mitchell; H al Mardini; C O Record
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

4.  Agonist and antagonist benzodiazepine receptor interaction in vitro.

Authors:  H Möhler; J G Richards
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  Evaluation of visual function in healthy subjects after administration of Ro 15-1788.

Authors:  Y Lupolover; A B Safran; D Desangles; C de Weisse; J J Meyer; A Bousquet; A Assimacopoulos
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Different susceptibilities of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease (a combined neurophysiological-neuropathological study).

Authors:  U Aguglia; D Gambarelli; G Farnarier; A Quattrone
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1991-06

7.  Feasibility of reversing benzodiazepine tolerance with flumazenil.

Authors:  I Savic; L Widén; S Stone-Elander
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

8.  Distribution and plasticity of immunocytochemically localized GABAA receptors in adult monkey visual cortex.

Authors:  S H Hendry; J Fuchs; A L deBlas; E G Jones
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

9.  The binocular input to cells in the feline dorsal lateral geniculate nucleus (dLGN).

Authors:  P C Murphy; A M Sillito
Journal:  J Physiol       Date:  1989-08       Impact factor: 5.182

Review 10.  Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).

Authors:  U Klotz; J Kanto
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.